Results
1 -
10 of
13Acid-Sensitive Prodrugs of Doxorubicin, Anthracycline Chemistry and Biology II Pharmaceutics of Nanoparticles, Nanomaterials in Pharmacology In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B, Cancer Chemotherapy and Pharmacology Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety, Journal of Cancer Research and Clinical Oncology Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin, Breast Cancer Research and Treatment Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors, Investigational New Drugs Objective: tumor. Strategies of drug targeting at the tumor mass level, Clinical and Translational Oncology Role of mtDNA lesions in anthracycline cardiotoxicity, Cardiovascular Toxicology US FDA places partial clinical hold on aldoxorubicin, Reactions Weekly ASCO update u2013 what is new in the systemic treatment of advanced soft tissue sarcomas?, memo - Magazine of European Medical Oncology